Medicare Enrolled
Dr. Archana Koganti, MD
Neurology · Marietta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Koganti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koganti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Koganti
Dr. Archana Koganti is a neurology specialist in Marietta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Koganti performed 918 Medicare services across 792 unique beneficiaries.
Between the years covered by Open Payments, Dr. Koganti received a total of $12,124 from 71 pharmaceutical and/or device companies across 637 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Koganti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in GA
$12,124 industry payments
Medicare Practice Summary
Medicare Utilization ↗918
Medicare services
Top 30% in GA for neurology
792
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~48 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
442 | $91 | $282 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
163 | $117 | $376 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
120 | $43 | $142 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
45 | $160 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $63 | $201 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
29 | $47 | $157 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $131 | $387 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
19 | $106 | $281 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
19 | $42 | $142 |
| EEG brain wave test, 61-119 minutes This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes. |
15 | $63 | $212 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,124
Total received (2018-2024)
Avg $1,732/year across 7 years
Top 23% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
637
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,913 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$211 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,710
2023
$2,183
2022
$1,114
2021
$1,430
2020
$731
2019
$2,924
2018
$2,031
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$497
ABBVIE INC.
$239
JAZZ PHARMACEUTICALS INC.
$145
PFIZER INC.
$139
Eisai Inc.
$115
ARGENX US, INC.
$81
Otsuka America Pharmaceutical, Inc.
$72
ACADIA Pharmaceuticals Inc
$70
Sumitomo Pharma America, Inc.
$52
Celgene Corporation
$46
NEUROPACE, INC.
$41
Amgen Inc.
$39
Lilly USA, LLC
$35
Teva Pharmaceuticals USA, Inc.
$34
Lundbeck LLC
$23
Octapharma USA, Inc.
$22
Neurelis, Inc.
$22
Biogen, Inc.
$21
Novartis Pharmaceuticals Corporation
$16
Top 3 companies account for 51.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,071
ABBVIE INC.
$863
ACADIA Pharmaceuticals Inc
$623
Teva Pharmaceuticals USA, Inc.
$614
Amgen Inc.
$592
JAZZ PHARMACEUTICALS INC.
$527
Sunovion Pharmaceuticals Inc.
$437
Alexion Pharmaceuticals, Inc.
$397
EMD Serono, Inc.
$360
Greenwich Biosciences, Inc.
$352
AbbVie Inc.
$299
Supernus Pharmaceuticals, Inc.
$290
Novartis Pharmaceuticals Corporation
$275
PFIZER INC.
$269
Biogen, Inc.
$268
ARGENX US, INC.
$260
Acorda Therapeutics, Inc
$225
GENZYME CORPORATION
$217
Eisai Inc.
$201
Celgene Corporation
$194
Allergan Inc.
$194
SK Life Science, Inc.
$193
Lundbeck LLC
$174
Allergan, Inc.
$171
Biohaven Pharmaceuticals, Inc.
$164
GE HEALTHCARE
$151
Neurelis, Inc.
$139
LivaNova USA, Inc.
$137
Promius Pharma LLC
$134
Grifols USA, LLC
$126
W. L. Gore & Associates, Inc.
$124
Avanir Pharmaceuticals, Inc.
$124
Neurocrine Biosciences, Inc.
$123
Biohaven Pharmaceutical Holding Company Ltd.
$118
UPSHER-SMITH LABORATORIES LLC
$118
US WorldMeds, LLC
$117
CSL Behring
$101
Sumitomo Pharma America, Inc.
$97
Adamas Pharmaceuticals, Inc.
$82
Bausch Health US, LLC
$80
Amneal Pharmaceuticals LLC
$78
EISAI INC.
$72
Otsuka America Pharmaceutical, Inc.
$72
GE Healthcare
$72
BANNER LIFE SCIENCES, LLC
$60
Mallinckrodt LLC
$60
Octapharma USA, Inc.
$56
Abbott Laboratories
$55
Upsher-Smith Laboratories LLC
$55
Janssen Pharmaceuticals, Inc
$53
Horizon Therapeutics plc
$47
Lilly USA, LLC
$46
NEUROPACE, INC.
$41
Mylan Pharmaceuticals Inc.
$32
Corium, LLC
$30
IMPEL PHARMACEUTICALS INC.
$29
Almatica Pharma LLC
$26
Kyowa Kirin, Inc.
$25
Catalyst Pharmaceuticals, Inc.
$24
Impax Laboratories, Inc.
$23
Alnylam Pharmaceuticals Inc.
$22
AQUESTIVE THERAPEUTICS, INC.
$19
Bard Peripheral Vascular, Inc.
$17
AbbVie, Inc.
$16
Cala Health, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$15
GE HealthCare
$14
ARBOR PHARMACEUTICALS, INC.
$14
Arbor Pharmaceuticals, Inc.
$13
Medtronic USA, Inc.
$11
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 21.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CALA TRIO · COMIRNATY · COPAXONE · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · Glatiramer Acetate · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LEQEMBI · LUMIZYME · Leqembi · MIGRANAL · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · POWERPORT · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · SOLIRIS · SPINRAZA · SYMPAZAN · Soliris · Solitaire · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · XYREM · XYWAV · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
219
Per 100K population
28.5
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Koganti is a clinical cardiology specialist, with above-average Medicare volume (top 30% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Koganti experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Koganti performed 442 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koganti receive payments from pharmaceutical companies?
Yes. Dr. Koganti received a total of $12,124 from 71 companies across 637 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koganti's costs compare to other neurologists in Marietta?
Dr. Koganti's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koganti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Marietta
Browse neurologists in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology